ArticleACR open rheumatology2023

Use of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: Supporting Shared Decision-Making Between Patients With Cancer and Clinicians.

Namrata Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.